✦ LIBER ✦

Long-term (4-year) safety of intravenous Ibandronate in metastatic breast cancer: an open-label study

✍ Scribed by M Pecherstorfer; I.J Diel; B Bergstrom

Book ID: 118622206
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 172 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)90858-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Safety of Intravenous Ibandron

Long-Term Safety of Intravenous Ibandronic Acid for Up to 4 Years in Metastatic Breast Cancer

✍ Dr Martin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, Ingo Diel, Bengt Bergst 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 110 KB

461 PUBLICATION Long-term safety of intr

461 PUBLICATION Long-term safety of intravenous ibandronate throughout 4 years of treatment for metastatic breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

444 PUBLICATION Long-term safety of oral

444 PUBLICATION Long-term safety of oral ibandronate for metastatic breast cancer: 4-year treatment data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Long-term safety of oral ibandronate in

Long-term safety of oral ibandronate in patients with skeletal metastases from breast cancer: 4-year follow-up data

✍ D Cameron; R Murray; D Tripathy; B Bergström 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Long-Term, Open-Label Safety and Efficac

Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study

✍ Adler, L. A.; Spencer, T. J.; Williams, D. W.; Moore, R. J.; Michelson, D. 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 84 KB

Safety of dienogest in the long-term tre

Safety of dienogest in the long-term treatment of endometriosis: a one-year, open-label, follow-up study

✍ C. Seitz; C. Gerlinger; T. Faustmann; T. Strowitzki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB